Back to results
US 2021/0199667 A1Published application
Analysis of soluble tlr7 in human-derived sample
AssigneeThe University of Tokyo
InventorsKensuke MIYAKE, Yusuke MURAKAMI, Yuji MOTOI, Toshiyuki SHIMIZU, Umeharu OHTO
Life of this patent
Estimating the term…
Abstract
An object of the present invention is to provide a technique for detecting human TLR7. Human TLR7 in a sample can be detected through an ELISA method or the like using an anti-human TLR7 antibody. The present invention enables use of human TLR7 as a marker indicating the pathological condition of an autoimmune disease.
Claims9
A method for analyzing a human-derived body fluid sample, comprising:
- detecting human TLR7 in a sample from a test subject by using an anti-human TLR7 antibody;
- and
- comparing a detection result on the sample from the test subject with a detection result on a sample derived from a healthy individual.
An agent for examining an autoimmune disease involving activation of TLR7, comprising an anti-human TLR7 antibody.
Dependencies are inferred from the claim text.